Chondrolectin Is a Novel Diagnostic Biomarker and a Therapeutic Target for Lung Cancer
Ken Masuda(Hiroshima City Asa Citizens Hospital), Yataro Daigo(The University of Tokyo), Eiju Tsuchiya(Kanagawa Prefectural Hospital Organization), Hirohiko Akiyama(Hiroshima University), Atsushi Takano(The University of Tokyo), Yusuke Nakamura(Rissho University), Nobuoki Kohno(Hiroshima University), Hideto Oshita(Hiroshima University)
Cited by 24
Related Papers
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
|Nature Genetics|2008|728
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593